1. MAXILLOFACIAL COMPLICATIONS IN SYSTEMIC CONDITIONS
1.1.CARDIOVASCULAR DISEASE
1.2. ENDOCRINOLOGICAL AND METABOLIC CONDITIONS
1.3. GASTROINTESTINAL AND PANCREATIC DISORDERS
1.4. HAEMATOLOGICAL DISEASE
1.5. HEPATOLOGICAL DISEASE
1.6. IATROGENIC CONDITIONS
1.7. IMMUNODEFICIENCIES
1.8. INFECTIONS
1.9. MENTAL DISEASE
1.10. MUCOSAL, CUTANEOUS AND MUCOCUTANEOUS DISEASE
1.11. NEOPLASTIC DISEASE
1.12. NEPHROLOGICAL DISEASE
1.13. NEUROLOGICAL DISEASE
1.14. RESPIRATORY DISEASE
1.15. RHEUMATOLOGICAL AND MUSCULOSKELETAL DISEASE
2. COMMON AND IMPORTANT DISORDERS AFFECTING MAXILLOFACIAL REGION: DIFFERENTIAL DIAGNOSIS BY SITE
2.1. LIPS
2.2. ORAL MUCOSA
2.3. TONGUE
2.4. PALATE AND FAUCES
2.5. GINGIVAE AND PERIODONTAL TISSUES
2.6. NECK
2.7. SALIVARY GLANDS
2.8. JAWS
2.9. TEMPOROMANDIBULAR JOINT DISORDERS
2.10. TEETH
2.11. MAXILLOFACIAL NEUROLOGICAL DISORDERS AND PAIN
3. DIFFERENTIAL DIAGNOSES AND MANAGEMENT
3.1. DIFFERENTIAL DIAGNOSES BY SYMPTOMS OR SIGNS
3.2. DIFFERENTIAL DIAGNOSES BY SITE
3.3. GUIDE TO THE DIAGNOSIS AND MANAGEMENT OF OROFACIAL DISEASES
3.4. GUIDE TO DRUGS USED IN THE MANAGEMENT OF OROFACIAL DISEASES
3.5. GUIDE TO THE OROFACIAL ADVERSE EFFECTS OF DRUG TREATMENT
INDEX
1.1.CARDIOVASCULAR DISEASE
1.2. ENDOCRINOLOGICAL AND METABOLIC CONDITIONS
1.3. GASTROINTESTINAL AND PANCREATIC DISORDERS
1.4. HAEMATOLOGICAL DISEASE
1.5. HEPATOLOGICAL DISEASE
1.6. IATROGENIC CONDITIONS
1.7. IMMUNODEFICIENCIES
1.8. INFECTIONS
1.9. MENTAL DISEASE
1.10. MUCOSAL, CUTANEOUS AND MUCOCUTANEOUS DISEASE
1.11. NEOPLASTIC DISEASE
1.12. NEPHROLOGICAL DISEASE
1.13. NEUROLOGICAL DISEASE
1.14. RESPIRATORY DISEASE
1.15. RHEUMATOLOGICAL AND MUSCULOSKELETAL DISEASE
2. COMMON AND IMPORTANT DISORDERS AFFECTING MAXILLOFACIAL REGION: DIFFERENTIAL DIAGNOSIS BY SITE
2.1. LIPS
2.2. ORAL MUCOSA
2.3. TONGUE
2.4. PALATE AND FAUCES
2.5. GINGIVAE AND PERIODONTAL TISSUES
2.6. NECK
2.7. SALIVARY GLANDS
2.8. JAWS
2.9. TEMPOROMANDIBULAR JOINT DISORDERS
2.10. TEETH
2.11. MAXILLOFACIAL NEUROLOGICAL DISORDERS AND PAIN
3. DIFFERENTIAL DIAGNOSES AND MANAGEMENT
3.1. DIFFERENTIAL DIAGNOSES BY SYMPTOMS OR SIGNS
3.2. DIFFERENTIAL DIAGNOSES BY SITE
3.3. GUIDE TO THE DIAGNOSIS AND MANAGEMENT OF OROFACIAL DISEASES
3.4. GUIDE TO DRUGS USED IN THE MANAGEMENT OF OROFACIAL DISEASES
3.5. GUIDE TO THE OROFACIAL ADVERSE EFFECTS OF DRUG TREATMENT
INDEX
Crispian Scully
Director of Special Projects at the UCL-Eastman Dental Institute (EDI); Professor of Special Care Dentistry, University College London; Chairman of International Federation of Oral Medicine; Past-President of European Association of Oral Medicine; President-elect of International Academy of Oral Oncology, member of the Hellenic Quality Assurance Agency for Higher Education, Member of Council, dental faculty of Royal College of Surgeons of Edinburgh, and member of International Committee of the American Academy for Oral Medicine. Co-director of the World Health Organisation Collaborating Centre for oral health, disability and culture.
He is also a member of UK Academy of Medical Sciences, a member of National Centre for Health and Clinical Excellence (NICE) working group on Oral Cancer and advisory subcommittee on CJD, a member of Higher Education Funding Council (HEFCE) Dental Research Review Panel, a member of Court of Middlesex University, a Trustee of Mouth Cancer Foundation, and member of Oral Cancer Foundation; Science Advisory Board. He has been for some years, Visiting Professor at the Universities of Bath, Bristol, Edinburgh, Helsinki, Hertfordshire, Middlesex and West of England.
He has written 30 and edited 11 books and > 860 papers cited on MEDLINE plus >300 others; his book Medical Problems in Dentistry was awarded the Doody Prize; and Oral and Maxillofacial Medicine won the Society of Authors Prize and BMA High Commendation. H
Director of Special Projects at the UCL-Eastman Dental Institute (EDI); Professor of Special Care Dentistry, University College London; Chairman of International Federation of Oral Medicine; Past-President of European Association of Oral Medicine; President-elect of International Academy of Oral Oncology, member of the Hellenic Quality Assurance Agency for Higher Education, Member of Council, dental faculty of Royal College of Surgeons of Edinburgh, and member of International Committee of the American Academy for Oral Medicine. Co-director of the World Health Organisation Collaborating Centre for oral health, disability and culture.
He is also a member of UK Academy of Medical Sciences, a member of National Centre for Health and Clinical Excellence (NICE) working group on Oral Cancer and advisory subcommittee on CJD, a member of Higher Education Funding Council (HEFCE) Dental Research Review Panel, a member of Court of Middlesex University, a Trustee of Mouth Cancer Foundation, and member of Oral Cancer Foundation; Science Advisory Board. He has been for some years, Visiting Professor at the Universities of Bath, Bristol, Edinburgh, Helsinki, Hertfordshire, Middlesex and West of England.
He has written 30 and edited 11 books and > 860 papers cited on MEDLINE plus >300 others; his book Medical Problems in Dentistry was awarded the Doody Prize; and Oral and Maxillofacial Medicine won the Society of Authors Prize and BMA High Commendation. H

